Alpine Immune Sciences Inc
General ticker "ALPN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.5B
Alpine Immune Sciences Inc follows the US Stock Market performance with the rate: 50.0%.
Estimated limits based on current volatility of 0.0%: low 64.95$, high 64.95$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 predicted range: [14.42$, 28.19$]
- 2024-12-30 to 2025-12-30 predicted range: [16.69$, 30.73$]
Financial Metrics affecting the ALPN estimates:
- Negative: Non-GAAP EPS of -0.67 <= 0.08
- Negative: Operating Income to Revenue ratio of -0.43 <= 0.01
- Negative: Operating Cash Flow per share of -1.58 <= 0.20
- Negative: negative Net Income
- Negative: Industry Earnings per Price (median) of -0.28 <= 0.01
Short-term ALPN quotes
Long-term ALPN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $23.44MM | $30.06MM | $58.88MM |
| Operating Expenses | $73.30MM | $88.21MM | $103.13MM |
| Operating Income | $-49.86MM | $-58.15MM | $-44.25MM |
| Non-Operating Income | $-0.56MM | $2.71MM | $12.17MM |
| Interest Expense | $0.82MM | $0.48MM | $0.10MM |
| R&D Expense | $58.74MM | $70.24MM | $80.33MM |
| Income(Loss) | $-50.42MM | $-55.43MM | $-32.08MM |
| Taxes | $-0.09MM | $2.33MM | $0.10MM |
| Profit(Loss) | $-50.33MM | $-57.76MM | $-32.18MM |
| Stockholders Equity | $120.90MM | $179.42MM | $327.94MM |
| Assets | $255.90MM | $286.69MM | $381.81MM |
| Operating Cash Flow | $-15.25MM | $-43.75MM | $-79.01MM |
| Investing Cash Flow | $-52.48MM | $-113.35MM | $-55.56MM |
| Financing Cash Flow | $100.76MM | $102.69MM | $165.12MM |
| Earnings Per Share* | $-1.98 | $-1.73 | $-0.64 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.